L C Pop1, D Sukumar2, S H Schneider3, Y Schlussel1, T Stahl4, C Gordon5, X Wang3, T V Papathomas6, S A Shapses7. 1. Department of Nutritional Sciences, Rutgers University, 96 Lipman Drive, New Brunswick, NJ, 08901-8525, USA. 2. Department of Nutritional Sciences, Drexel University, Philadelphia, PA, USA. 3. Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA. 4. Department of Radiology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA. 5. Department of Radiology, McMaster University, Hamilton, Ontario, Canada. 6. Department of Biomedical Engineering & Center for Cognitive Science, Rutgers University, New Brunswick, NJ, USA. 7. Department of Nutritional Sciences, Rutgers University, 96 Lipman Drive, New Brunswick, NJ, 08901-8525, USA. shapses@aesop.rutgers.edu.
Abstract
The effects of higher than recommended vitamin D doses on bone mineral density (BMD) and quality are not known. In this study, higher intakes, in postmenopausal women undergoing weight control over 1 year, had no effect on areal or volumetric BMD but prevented the deterioration in cortical bone geometry. INTRODUCTION: Studies examining how bone responds to a standard dose of vitamin D supplementation have been inconsistent. In addition, the effects of higher doses on BMD and quality are not known. Postmenopausal women undergoingweight control to improve health outcomes are particularly at risk for bone loss and might benefit from supplemental vitamin D intake above the recommended allowance. METHODS: This 1-year-long, randomized, double-blind controlled study addresses whether vitamin D supplementation, in healthy overweight/obese older women, affects BMD and bone structural parameters. In addition, bone turnover and serum total, free, and bioavailable 25-hydroxyvitamin D (25OHD) responses to one of three daily levels of vitamin D3 (600, 2000, 4000 IU) with 1.2 Ca g/day during weight control were examined. RESULTS:Fifty-eight women (age, 58 ± 6 years; body mass index, 30.2 ± 3.8 kg/m2, serum 25OHD, 27.3 ± 4.4 ng/mL) were randomized to treatment. After 1 year, serum 25OHD concentrations increased to 26.5 ± 4.4, 35.9 ± 4.5, and 41.5 ± 6.9 ng/mL, in groups 600, 2000, and 4000 IU, respectively, and differed between groups (p < 0.01). Weight change was similar between groups (-3.0 ± 4.1 %). Cortical (Ct) thickness of the tibia changed by -1.5 ± 5.1 %, +0.6 ± 3.2 %, and +2.0 ± 4.5 % in groups 600, 2000, and 4000 IU, respectively, and each group was significantly different from each other (p < 0.05). CONCLUSION: The decline in Ct thickness was prevented with higher vitamin D3 supplementation, but there were no other significant changes due to treatment over 1 year. Whether these findings translate to changes in biomechanical properties leading to reduced fracture risk should be addressed in future studies.
RCT Entities:
The effects of higher than recommended vitamin D doses on bone mineral density (BMD) and quality are not known. In this study, higher intakes, in postmenopausal women undergoing weight control over 1 year, had no effect on areal or volumetric BMD but prevented the deterioration in cortical bone geometry. INTRODUCTION: Studies examining how bone responds to a standard dose of vitamin D supplementation have been inconsistent. In addition, the effects of higher doses on BMD and quality are not known. Postmenopausal women undergoing weight control to improve health outcomes are particularly at risk for bone loss and might benefit from supplemental vitamin D intake above the recommended allowance. METHODS: This 1-year-long, randomized, double-blind controlled study addresses whether vitamin D supplementation, in healthy overweight/obese older women, affects BMD and bone structural parameters. In addition, bone turnover and serum total, free, and bioavailable 25-hydroxyvitamin D (25OHD) responses to one of three daily levels of vitamin D3 (600, 2000, 4000 IU) with 1.2 Ca g/day during weight control were examined. RESULTS: Fifty-eight women (age, 58 ± 6 years; body mass index, 30.2 ± 3.8 kg/m2, serum 25OHD, 27.3 ± 4.4 ng/mL) were randomized to treatment. After 1 year, serum 25OHD concentrations increased to 26.5 ± 4.4, 35.9 ± 4.5, and 41.5 ± 6.9 ng/mL, in groups 600, 2000, and 4000 IU, respectively, and differed between groups (p < 0.01). Weight change was similar between groups (-3.0 ± 4.1 %). Cortical (Ct) thickness of the tibia changed by -1.5 ± 5.1 %, +0.6 ± 3.2 %, and +2.0 ± 4.5 % in groups 600, 2000, and 4000 IU, respectively, and each group was significantly different from each other (p < 0.05). CONCLUSION: The decline in Ct thickness was prevented with higher vitamin D3 supplementation, but there were no other significant changes due to treatment over 1 year. Whether these findings translate to changes in biomechanical properties leading to reduced fracture risk should be addressed in future studies.
Entities:
Keywords:
Body weight; Cortical thickness; Postmenopausal; Serum 25OHD; Vitamin D
Authors: Mariana Cifuentes; Claudia S Riedt; Robert E Brolin; M Paul Field; Robert M Sherrell; Sue A Shapses Journal: Am J Clin Nutr Date: 2004-07 Impact factor: 7.045
Authors: Andy K O Wong; Karen A Beattie; Kevin K H Min; Colin E Webber; Christopher L Gordon; Alexandra Papaioannou; Angela M W Cheung; Jonathan D Adachi Journal: J Clin Densitom Date: 2014-08-13 Impact factor: 2.617
Authors: Lucy Cooper; Phillip B Clifton-Bligh; M Liza Nery; Gemma Figtree; Stephen Twigg; Emily Hibbert; Bruce G Robinson Journal: Am J Clin Nutr Date: 2003-05 Impact factor: 7.045
Authors: Fulvio Lauretani; Stefania Bandinelli; Michael E Griswold; Marcello Maggio; Richard Semba; Jack M Guralnik; Luigi Ferrucci Journal: J Bone Miner Res Date: 2008-03 Impact factor: 6.741
Authors: J Mardon; A Zangarelli; S Walrand; M J Davicco; P Lebecque; C Demigné; M N Horcajada; Y Boirie; V Coxam Journal: Br J Nutr Date: 2007-10-10 Impact factor: 3.718
Authors: Sue A Shapses; Deeptha Sukumar; Stephen H Schneider; Yvette Schlussel; Robert M Sherrell; M Paul Field; Hasina Ambia-Sobhan Journal: Am J Clin Nutr Date: 2013-01-30 Impact factor: 7.045
Authors: Camille E Powe; Catherine Ricciardi; Anders H Berg; Delger Erdenesanaa; Gina Collerone; Elizabeth Ankers; Julia Wenger; S Ananth Karumanchi; Ravi Thadhani; Ishir Bhan Journal: J Bone Miner Res Date: 2011-07 Impact factor: 6.741
Authors: Helen M Macdonald; Adrian D Wood; Lorna S Aucott; Alison J Black; William D Fraser; Alexandra Mavroeidi; David M Reid; Karen R Secombes; William G Simpson; Frank Thies Journal: J Bone Miner Res Date: 2013-10 Impact factor: 6.741
Authors: Lauren A Burt; Emma O Billington; Marianne S Rose; Duncan A Raymond; David A Hanley; Steven K Boyd Journal: JAMA Date: 2019-08-27 Impact factor: 56.272
Authors: Julia Amariti; Brandon D McGuire; Anna R Ogilvie; Kristen M Beavers; Karen E Hansen; Yvette Schlussel; Michael P Walkup; Sue A Shapses Journal: Calcif Tissue Int Date: 2022-04-06 Impact factor: 4.000
Authors: Tao Zhou; Dianjianyi Sun; Xiang Li; Yoriko Heianza; Meryl S LeBoff; George A Bray; Frank M Sacks; Lu Qi Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045